Corporate news
Grifols opens new plasma fractionation plant in Spain The company has invested over 20 million euros, doubling its plasma fractionation capacity in Spain
+ info
+ info
Japanese Red Cross selects Grifols as partner for nucleic acid screening of nation's blood supply Japanese Red Cross will use the Procleix® Panther® platform to screen approximately 5.3 million blood donations each year for HIV and Hepatitis viruses
+ info
+ info
Grifols' sales rose by 4.6% to Euros 2,741.7 million In 2013 Grifols maintained its position as the third largest producer of plasma derivatives
+ info
+ info
Highlights
Manufacturing
We are a solid company with an international dimension.
Corporate Commitment
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.
Martín Villar Haemostasis Awards
Grifols is holding the seventh edition of the Martin Villar Awards for Research in Haemostasis. + info
